Business Combination - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Mar. 04, 2026 |
Mar. 31, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Business Combination [Line Items] | ||||
| Contingent consideration | $ 2,483 | $ 2,483 | ||
| Initial cash purchase price, net of cash acquired | 11,017 | $ 0 | ||
| Non-cash gain from settlement | 3,858 | $ 0 | ||
| UK Biocentre | ||||
| Business Combination [Line Items] | ||||
| Purchase price, net of cash acquired | $ 27,474 | |||
| Contingent consideration | 2,483 | |||
| Initial cash purchase price, net of cash acquired | 11,017 | |||
| Non-cash gain from settlement | 3,900 | |||
| Preexisting contractual liability settlement | 13,841 | |||
| Estimated fair value of contingent consideration | $ 2,500 | |||
| Liability | $ 2,500 | $ 2,500 | ||
| UK Biocentre | Trademarks | ||||
| Business Combination [Line Items] | ||||
| Estimated useful life | 7 years | |||
| X | ||||||||||
- Definition Business Combination, Consideration Transferred, Payable Settlement Amount No definition available.
|
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability arising from contingency in business combination, measured at acquisition-date fair value and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability assumed in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net gains or losses recognized for each transaction with the acquiree that was recognized separately from the acquisition of assets and assumptions of liabilities in the business combination. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|